Session Information
Session Type: ACR Poster Session A
Session Time: 9:00AM-11:00AM
Background/Purpose: Targeting IL-23 to treat autoimmune disease and chronic inflammation is currently in development based on its pro-inflammatory function via regulating the activation of Th17 cells. IL-23 was previously shown to be important for promoting pathogenic autoantibody production in Fas deficient B6-Faslpr/lpr mice, suggesting the positive role of IL-23 in mediating Fas-independent germinal center (GC) responses. In contrast, the lack of IL-23 did not influence conventional GC formation and IgG anti-CII autoantibodies in type II collagen immunized DBA/1 mice. We determined if IL-23 could regulate development of GCs and pathogenic autoantibody production in BXD2 mice.
Methods: The BXD2-IL-23 p19–⁄– mice were generated by 10 generation crossing the B6-p19–⁄– with the BXD2 mice. Serum autoantibodies were determined by ELISA. GC development was measured by FACS (GL-7 and Fas) and confocal imaging analyses. Autoantibody class switching was enumerated by the percentage of (IgM–IgD–) in GL-7+ B cells. Immune complex deposition (IgM and IgG) in kidney was detected by confocal imaging.
Results: There was lower induction of Il17a in subpopulations of spleen cells from BXD2-p19–⁄– mice compared to WT BXD2 mice. However, unlike BXD2-Il17ra–⁄– mice, which developed lower levels of both IgM and IgG autoantibodies, BXD2-p19–⁄– mice exhibited significantly elevated titer of total IgM and IgM anti-DNA and RF autoantibodies but significantly lower levels of total IgG and IgG anti-histone, compared to WT BXD2 mice. Despite the lower circulating IgG autoantibodies, IgG staining was significantly increased in the glomerulus of BXD2-p19–⁄– mice compared to BXD2 and normal B6 mice with both an immune complex and linear staining pattern. The number and size of PNA+ GCs and the percent of GL-7+Fas+ GC B cells were increased in BXD2-p19–⁄– mice comparable to WT BXD2 mice. Abnormal GC development kinetics was confirmed by increased conventional isotype switched IgM–IgD– GL7+Fas+ B cells in BXD2-p19–⁄– mice compared to BXD2 WT mice.
Conclusion: The present findings provide a potential link to consolidate previous findings on the importance of IL-23 in mediating IgG autoantibody development in B6-Faslpr/lpr mice and the lack of effects in development of IgG anti-CII antibody in CII immunized IL-23 deficient mice. These results extend the paradigm of IL-23 disease beyond the classical IL23-Th17 axis and suggest IL-23 exhibits a negative effect on development of classical GC B cells that produce highly pathogenic autoAbs.
To cite this abstract in AMA style:
Hong H, Wu Q, Yang P, Luo B, Li J, Li H, Cua D, Hsu HC, Mountz JD. IL-23 Regulates Development of Spontaneous Germinal Centers and Pathogenic Autoantibody Production in BXD2 Mice [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/il-23-regulates-development-of-spontaneous-germinal-centers-and-pathogenic-autoantibody-production-in-bxd2-mice/. Accessed .« Back to 2017 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/il-23-regulates-development-of-spontaneous-germinal-centers-and-pathogenic-autoantibody-production-in-bxd2-mice/